Crusoe
AI infrastructure combining GPU cloud services, managed AI tools, large-scale data centers and modular AI factories for model developers and enterprises.
>$3.9BSeries F
LeadActivity from announced rounds
AI infrastructure combining GPU cloud services, managed AI tools, large-scale data centers and modular AI factories for model developers and enterprises.
Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
Develops regenerative biologics to restore tissue function